Efficient engineering of vascularized ectopic bone from human embryonic stem cell-derived mesenchymal stem cells

Tissue Engineering - Part A

Volumn 18, Issue 21-22, 2012, Pages 2290-2302

  Domev, Hagit ^a   Amit, Michal ^a   Laevsky, Ilana ^a   Dar, Ayelet ^a   Itskovitz Eldor, Joseph ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Rambam Health Care Campus ^*  (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOGENIC; BONE REPAIR; CELL THERAPY; CELL TYPES; CHONDROCYTIC; COCULTURE; ECTOPIC BONES; EMBRYONIC STEMS; HUMAN EMBRYONIC STEM CELLS; HUMAN MESENCHYMAL STEM CELLS (HMSCS); IN-VITRO; IN-VIVO; LARGE-SCALE PRODUCTION; MESENCHYMAL STEM CELL; OSTEOCALCIN; OSTEOGENIC DIFFERENTIATION; STROMAL CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

BLOOD VESSELS; BONE; CELL GROWTH; HISTOLOGY; STEM CELLS; TISSUE; TISSUE ENGINEERING;

CELL CULTURE;

MURINAE;

COLLAGEN; LAMININ; MATRIGEL; OSTEOCALCIN; PROTEOGLYCAN; VASCULOTROPIN A;

ADIPOCYTE; ANGIOGENESIS; ANIMAL; ARTICLE; BONE; BONE DEVELOPMENT; CARTILAGE CELL; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL SEPARATION; CHORISTOMA; COCULTURE; CYTOLOGY; DRUG COMBINATION; DRUG EFFECT; EMBRYONIC STEM CELL; HUMAN; KINETICS; MESENCHYMAL STROMA CELL; METABOLISM; METHODOLOGY; MOUSE; MOUSE MUTANT; OSTEOBLAST; PATHOLOGY; SECRETION (PROCESS); STROMA CELL; TISSUE ENGINEERING; VASCULARIZATION;

ADIPOCYTES; ANIMALS; BONE AND BONES; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL SEPARATION; CHONDROCYTES; CHORISTOMA; COCULTURE TECHNIQUES; COLLAGEN; DRUG COMBINATIONS; EMBRYONIC STEM CELLS; HUMANS; KINETICS; LAMININ; MESENCHYMAL STROMAL CELLS; MICE; MICE, SCID; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; PROTEOGLYCANS; STROMAL CELLS; TISSUE ENGINEERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84868575262     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0371     Document Type: Article

References (40)

1. Friedenstein, A.J., et al. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17, 331, 1974.
2. Javazon, E.H., Beggs, K.J., and Flake, A.W. Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 32, 414, 2004.
3. Pittenger, M.F., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
4. Horwitz, E.M., et al. Isolated allogeneic bone marrowderived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 99, 8932, 2002.
5. Horwitz, E.M., et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97, 1227, 2001.
6. Bigdeli, N., et al. Superior osteogenic capacity of human embryonic stem cells adapted to matrix-free growth compared to human mesenchymal stem cells. Tissue Eng Part A 16, 3427, 2010.
7. Kassem, M., and Abdallah, B.M. Human bone-marrowderived mesenchymal stem cells: biological characteristics and potential role in therapy of degenerative diseases. Cell Tissue Res 331, 157, 2008.
8. Zuk, P.A., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7, 211, 2001.
9. Arpornmaeklong, P., et al. Expansion and characterization of human embryonic stem cell-derived osteoblast-like cells. Cell Reprogram 12, 377, 2010.
10. Trivedi, P., and Hematti, P. Simultaneous generation of CD34+ primitive hematopoietic cells and CD73+ mesenchymal stem cells from human embryonic stem cells cocultured with murine OP9 stromal cells. Exp Hematol 35, 146, 2007.
11. Barberi, T., et al. Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med 2, e161, 2005.
12. Olivier, E.N., Rybicki, A.C., and Bouhassira, E.E. Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. Stem Cells 24, 1914, 2006.
13. Trivedi, P., and Hematti, P. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp Hematol 36, 350, 2008.
14. Harkness, L., et al. Selective isolation and differentiation of a stromal population of human embryonic stem cells with osteogenic potential. Bone 48, 231, 2010.
15. Karlsson, C., et al. Human embryonic stem cell-derived mesenchymal progenitors-potential in regenerative medicine. Stem Cell Res 3, 39, 2009.
16. Lian, Q., et al. Derivation of clinically compliant MSCs from CD105 + , CD24-differentiated human ESCs. Stem Cells 25, 425, 2007.
17. Barberi, T., et al. Derivation of engraftable skeletal myoblasts from human embryonic stem cells. Nat Med 13, 642, 2007.
18. Arpornmaeklong, P., et al. Phenotypic characterization, osteoblastic differentiation, and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells. Stem Cells Dev 18, 955, 2009.
19. Bielby, R.C., et al. In vitro differentiation and in vivo mineralization of osteogenic cells derived from human embryonic stem cells. Tissue Eng 10, 1518, 2004.
20. Koob, S., et al. Bone formation and neovascularization mediated by mesenchymal stem cells and endothelial cells in critical-sized calvarial defects. Tissue Eng Part A 17, 311, 2011.
21. Carlevaro, M.F., et al. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J Cell Sci 113 (Pt 1), 59, 2000.
22. Carano, R.A., and Filvaroff, E.H. Angiogenesis and bone repair. Drug Discov Today 8, 980, 2003.
23. Gerber, H.P., and Ferrara, N. Angiogenesis and bone growth. Trends Cardiovasc Med 10, 223, 2000.
24. Cross, M.J., et al. VEGF-receptor signal transduction. Trends Biochem Sci 28, 488, 2003.
25. Ferrara, N., Gerber, H.P., and LeCouter, J. The biology of VEGF and its receptors. Nat Med 9, 669, 2003.
26. Neufeld, G., et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13, 9, 1999.
27. Maes, C., et al. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech Dev 111, 61, 2002.
28. Street, J., et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99, 9656, 2002.
29. Boiret, N., et al. Characterization of nonexpanded mesenchymal progenitor cells from normal adult human bone marrow. Exp Hematol 33, 219, 2005.
30. Peng, H., et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110, 751, 2002.
31. Mayer, H., et al. Vascular endothelial growth factor (VEGFA) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem 95, 827, 2005.
32. Amit, M., and Itskovitz-Eldor, J. Derivation and spontaneous differentiation of human embryonic stem cells. J Anat 200(Pt 3), 225, 2002.
33. Thomson, J.A., et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145, 1998.
34. Itskovitz-Eldor, J., et al. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med 6, 88, 2000.
35. Kern, J., et al. Vasohibin inhibits angiogenic sprouting in vitro and supports vascular maturation processes in vivo. BMC Cancer 9, 284, 2009.
36. Dar, A., et al. Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb. Circulation 125, 87, 2012.
37. Amit, M., et al. Human feeder layers for human embryonic stem cells. Biol Reprod 68, 2150, 2003.
38. Amit, M., et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 227, 271, 2000.
39. Melero-Martin, J.M., et al. Engineering robust and functional vascular networks in vivo with human adult and cord bloodderived progenitor cells. Circ Res 103, 194, 2008.
40. Lian, Q., et al. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 121, 1113, 2010.